Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us

Global Infection Control for the Human and Animal Health Market Overview

Infection Control for the Human and Animal Health Market size was valued at USD 8.74 billion in 2022. The Infection Control for the Human and Animal Health Market industry is projected to grow from USD 9.56 billion in 2023 to USD 20.95 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.16% during the forecast period (2023 - 2032).

The factors that are driving the growth of the global market are increasing prevalence of infectious diseases and rising awareness of infection control measures.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Infection Control for the Human and Animal Health Market Trends

• Increasing prevalence of infectious diseases

The increasing prevalence of infectious diseases serves as a significant driver for Infection Control for the Human and Animal Health Market. In recent years, there has been a notable surge in the prevalence of various infectious diseases worldwide, contributing to an increased demand for infection control products and measures. According to the World Health Organization (WHO), infectious diseases remain a leading cause of global morbidity and mortality, affecting millions of people annually. For instance, the COVID-19 pandemic, caused by the novel coronavirus (SARS-CoV-2), has underscored the importance of effective infection control strategies. As of January 21, 2024, latest available statistics by Worldometer, the total number of confirmed COVID-19 cases globally is approximately 702,115,249. Moreover, other infectious diseases such as influenza, bacterial infections, parasitic diseases, and fungal infections continue to pose significant public health challenges. According to the WHO, in 2022, there were approximately 249 million malaria cases and 608,000 malaria deaths in 85 countries.

The rising awareness of infection control measures represents a pivotal driver for Infection Control for the Human and Animal Health Market. Heightened public and professional awareness about the importance of infection prevention has been fostered by the experiences of recent pandemics and global health crises. Increased media coverage, educational campaigns, and government initiatives have contributed to a more informed populace and healthcare community. Individuals and healthcare professionals alike are recognizing the critical role of disinfection products, personal protective equipment (PPE), and sterilization equipment in curbing the spread of infectious diseases. With a growing emphasis on infection control protocols in various settings, including hospitals, clinics, and public spaces, there is a corresponding surge in the demand for advanced and effective infection control solutions.  

The increasing number of infectious diseases is driving a higher demand worldwide for infection control in both human and animal health sectors. This is primarily due to increased awareness and the urgent need for effective measures in addressing pandemics and ongoing public health issues.

Infection Control for the Human and Animal Health Market Segment Insights:

Infection Control for the Human and Animal Health Market Product Insights

Based on product, the Infection Control for the Human and Animal Health Market is segmented into disinfection products, personal protective equipment (PPE)​, and sterilization equipment. Disinfection products is divided into liquid disinfectants​, disinfectant wipes​, disinfectant sprays​, and others​; personal protective equipment (PPE) is segregated into gloves​, masks, gowns​, protective eyewear​, and others, and ​ sterilization equipment segment is segmented into Heat sterilization equipment​, low-temperature sterilization equipment​, radiation sterilization equipment​, and filtration sterilization equipment.  Personal protective equipment (PPE) held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2032. This growth is attributed to increasing demands for gloves, masks, gowns, and protective eyewear in human healthcare and animal facilities. Gloves, in particular, are indispensable in medical procedures, examinations, and patient care to prevent cross-contamination and ensure the safety of healthcare professionals and patients. Similarly, in animal health, gloves are crucial for various veterinary procedures, safeguarding both animals and veterinary personnel.

Infection Control for the Human and Animal Health Market Infection Type Insights

Based on infection type, the Infection Control for the Human and Animal Health Market has been segmented into viral​, bacterial​, parasitic​, and fungal infections. Bacterial​ held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2032. Bacterial infections are diseases that can affect the skin, lungs, brain, blood, and other organs of the body. Urinary tract infections (UTIs), food poisoning, sexually transmitted infections (STIs), and certain skin, sinus, and ear infections are a number of common bacterial diseases. The increasing number of UTI-infected people is fueling the growth of the market. For instance, in November 2022, the Urology Care Foundation reported that UTIs cause more than 8.1 million visits to healthcare providers each year in the US.

FIGURE 2: Infection Control For The Human And Animal Health Market, By Infection Type, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Infection Control for the Human and Animal Health Market End User Insights

Based on end user, the infection control for the human and animal health market is segmented into human healthcare facilities and ​animal healthcare facilities. Human healthcare facilities segment is segmented into hospitals & clinics​, ambulatory surgical centers​, others​ and ​animal healthcare facilities is segregated into ​veterinary hospitals​, animal shelters​, farming facilities​, and others. Human healthcare facilities held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period. Hospitals & clinics prioritize patient safety by implementing stringent infection control measures. This includes maintaining clean environments, proper sterilization of medical instruments, and adherence to protocols for preventing hospital-associated infections (HAIs). The use of PPE, such as masks, gloves, gowns, and face shields, is essential in hospitals and clinics to prevent the transmission of infectious agents during medical procedures, examinations, and patient care.

Infection Control for the Human and Animal Health Market Regional Insights

By region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World.

North America accounted for the largest market share of over 33.75% in 2022, owing to the increasing advanced healthcare infrastructure, stringent regulations, and high awareness regarding infection control measures and the rising number of surgical procedures in the region. PPE is frequently utilized in orthopedic surgery in order to prevent infections in patients and healthcare providers too. According to the American Joint Replacement Registry's 2021 annual report, there were 2,244,587 hip and knee procedures performed.

Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.

FIGURE 3: Infection Control For The Human And Animal Health Market, By Region, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe infection control for the human and animal health market shows significant growth during the forecast year, i.e., 2022–2023, owing to the increasing infections cases across the Europe. The infection control market in Europe, encompassing both human and animal health, is witnessing a robust surge driven by the increasing awareness of infectious diseases and the need for advanced preventive measures. According to the World Health Organisation on June 26, 2023, Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland have reported an increase in confirmed cases of E-11 infection in neonates and infants, with high morbidity and mortality. Furthermore, E-11 can be transmitted vertically from mother to child, complicating infection control efforts. The infections can cause severe inflammatory illnesses in neonates, such as severe acute hepatitis with coagulopathy. E-11 and other enteroviruses have been circulating continuously in Europe. Furthermore, the Germany infection control for the human and animal health market held the largest market share in 2022 and France infection control for the human and animal health market is the fastest growing market in the Europe region.

The Asia-Pacific region is a dynamic and diverse market for infection control in both human and animal health. With a rapidly growing population, increased urbanization, and rising awareness about healthcare standards, the demand for effective infection prevention and control measures is on the rise. According to the United Nations Population Fund (UNFPA), Asia and the Pacific account for 60% of the world's population, or approximately 4.3 billion people. Furthermore, an increasing in population density not only affects the spread of infectious diseases directly (for example, through increased human-to-human contact), but it also underpins many other ecological driving forces such as changing land use, agriculture, and livestock intensification. Moreover, China infection control for the human and animal health market held the largest market share in 2022 and India infection control for the human and animal health market is the fastest growing market in the Asia-Pacific region.

Infection Control for the Human and Animal Health Key Market Players & Competitive Insights

The Infection Control for the Human and Animal Health Market is characterized by the presence of many global, regional, and local players and factors such as lowering the cost of the products, improving infrastructure and increasing adoption of infection control products are driving the growth of the Infection Control for the Human and Animal Health Market. To expand their reach and optimize their operational costs, the major players focus on forming strategic and in order to gain a substantial market share.

Advanced Sterilization Products (US) is a leader in infection prevention, dedicated to developing the products, solutions, and processes that practitioners require to protect patients. It offers products through categories such as terminal sterilization, sterilization monitoring, high-level disinfection, and connectivity. Its terminal sterilization (TS) solutions to assist in the quick and compliant reprocessing of surgical instruments. It has more than 1,700 employees across 100 countries. It has presence across region’s namely Americas, Europe, Asia-Pacific, Middle East & Africa. Moreover, in April 2019, the company launched AEROFLEX Automatic Endoscope Reprocessor (AER), a single basin system automates the washing and high-level disinfection cycle of flexible semi-critical endoscopes. This launch has helped the company expand its reach in developing regions and generate sales.

Key Companies in the Infection Control for the Human and Animal Health Market includes.

• Advanced Sterilization Products (US)


• STERIS plc (Ireland)


• Getinge AB (Sweden)


• Virox Technologies, Inc. (Canada)


• 3M (US)


• Zoetis Animal Healthcare (US)


• PeproTech Sciences Inc (Canada)


• Neogen Corporation (US)


• Cardinal Health (US)


• Stryker (US)

Infection Control for the Human and Animal Health Industry Developments

November 2023:Cardinal Health (US) launched the SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets. The SmartGown EDGE, the first surgical gown with pockets, is designed to keep instruments sterile and easily accessible. The unique gown pocket design lowers the risk of cross-contamination and unintentional instrument drops outside the sterile area.

November 2022:Neogen (US) launched Synergize Disinfectant in Europe, the Middle East, and Africa. Synergize is a multifunctional disinfectant that eradicates viruses, spores, fungi, bacteria, and microorganisms of both Gram and Gram-negative types. Synergize can be used in combination with Neogen’s comprehensive suite of biosecurity products, including apparel, cleaners, and disinfectants.

January 2021:Stryker (US) unveiled T7TM, their next-generation personal defense system. The T7 and T7plus offer a personalized personal protection system that keeps users cool and comfortable during surgical procedures without sacrificing protection.

Infection Control for the Human and Animal Health Market Segmentation:

Infection Control for the Human and Animal Health Product Outlook

• Disinfection Products
  
  
  
  • Liquid Disinfectants​
  
  
  • Disinfectant Wipes​
  
  
  • Disinfectant Sprays​
  
  
  • Others​
  
  
  
  


• Personal Protective Equipment (PPE)​
  
  
  
  • Gloves​
  
  
  • Masks
  
  
  • Gowns​
  
  
  • Protective Eyewear​
  
  
  • Others​
  
  
  
  


• Sterilization Equipment
  
  
  
  • Heat Sterilization Equipment​
  
  
  • Low-temperature Sterilization Equipment​
  
  
  • Radiation Sterilization Equipment​
  
  
  • Filtration Sterilization Equipment
  
  
  
  

Infection Control for the Human and Animal Health Infection Type Outlook

• Viral​


• Bacterial​


• Parasitic​


• Fungal Infections

Infection Control for the Human and Animal Health End User Outlook

• Human Healthcare Facilities
  
  
  
  • Hospitals & Clinics​
  
  
  • Ambulatory Surgical Centers​
  
  
  • Others​
  
  
  
  


• ​Animal Healthcare Facilities
  
  
  
  • ​Veterinary Hospitals​
  
  
  • Animal Shelters​
  
  
  • Farming Facilities​
  
  
  • Others
  
  
  
  

Infection Control for the Human and Animal Health Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America